Skip to Content
941

Alexion Pharmaceuticals

  • Previous Rank-
  • Revenues ($M)2,234
  • Revenue Percent Change44%
  • Profits ($M)657
  • Profits Percent Change159.8%
  • Market Value (as of March 31, 2015)35,032
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
David L. Hallal
Industry
Pharmaceuticals
Sector
Health Care
HQ Location
Cheshire, CT
Websitehttp://www.alexion.com
Years on List-

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)2,23444%
Profits ($M)657159.8%
Total Stockholder Equity3,302-
Employees2,273-
Market Value (as of March 31, 2015)35,032-

Profit Ratios

Profit as % of Revenues29.4%
Profits as % of Assets15.6%
Profits as % of Stockholder Equity19.9%

Earnings Per Share (last fiscal year)

Earnings Per Share ($)3.26
EPS % Change (from 2013)156.7%
EPS % Change (5 year annual rate)14.9%
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2014)39.2%
Total Return to Investors (5 year, annualized)49.9%
Total Return to Investors (10 year, annualized)40.2%